Prospera Financial Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$379K Sell
2025
Q2
$297K Buy
2024
Q3
Sell
2024
Q2
$206K Sell
2024
Q1
$287K Buy
2022
Q3
Sell
2022
Q2
$82K Sell
2022
Q1
$100K Buy
2020
Q4
Sell
2020
Q3
$50K Buy